共 299 条
[1]
Jemal A(2010)Cancer statistics, 2010 CA Cancer J Clin 60 277-300
[2]
Siegel R(2002)Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer Gut 51 65-69
[3]
Xu J(2007)Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology Gut 56 1419-1425
[4]
Ward E(2002)Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer J Clin Oncol 20 3999-4005
[5]
Petersen VC(2004)Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22 1797-1806
[6]
Baxter KJ(2005)Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group Acta oncologica (Stockholm, Sweden) 44 904-912
[7]
Love SB(2006)Current issues in adjuvant treatment of stage II colon cancer Ann Surg Oncol 13 887-898
[8]
Shepherd NA(2000)Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee Archives of pathology & laboratory medicine 124 1016-1025
[9]
Morris EJ(1998)For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis Cancer 83 666-672
[10]
Maughan NJ(1994)Colorectal adenocarcinoma: quality of the assessment of lymph node metastases Diseases of the colon and rectum 37 373-376